Market Update: Regeneron, UPS, and Zebra
Regeneron (REGN) has seemingly ended its bear phase, with shares rising by 12% to over $650 after bottoming out at $550-$575.
The company reported a 0.8% increase in revenue to $3.75 billion, driven by strong sales of Dupixent, which reached $4.9 billion. This offset weak sales from EYLEA, although EYLEA HD sales grew by 42% to $663 million.
UPS, despite being down 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion. The company announced a significant 48,000 job cut, with 34,000 cuts in operational units and 14,000 at the management level.
Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
No specific quote available in the given text.
Author's summary: Stocks show mixed results with Regeneron rising.
- Regeneron (REGN): shares rose 12% to over $650
- UPS: added 8.0% after posting results and announcing job cuts
- Zebra (ZBRA): continued downtrend, losing 11%
More News
- Yankees’ promising catcher is the key to unlocking the bottom of the lineup’s ceiling
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- Political agenda in the presentation of student demands
- NBA approves $10 billion Lakers sale to Mark Walter
- We warned about the invisible ringleaders and the fact that the students’ interests have been submerged in the political ambitions of certain individuals
- Red Sox Are Playing with Fire if Alex Bregman Doesn't Return in 2026
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- Mookie Betts Trade Piece Has Worn Out His Welcome in Boston After 2025
- Thunder GM Sam Presti shares gut-wrenching Nikola Topic health news
- These celebs have confessed about sex with other celebs